XML 24 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Cash flows from operating activities:      
Net income $ 14,877 $ 46,354 $ 26,610
Adjustments to reconcile net income to cash flow from operating activities:      
Depreciation and amortization 60,687 52,815 45,221
Amortization of deferred financing costs, net 1,448 1,423 1,430
Stock compensation expense 5,564 3,116 2,524
(Gain on sale) loss on impairment of real estate assets, net (7,554) (35,211) (10,650)
Amortization related to derivative instruments 1,200 690 (40)
Casualty losses 711 0 46
Changes in assets and liabilities:      
Other assets (2,428) 1,344 (514)
Accounts payable and accrued expenses 754 3,490 3,284
Accrued interest payable (182) 1,542 469
Other liabilities (118) (562) 196
Net cash provided by operating activities 74,959 75,001 68,530
Cash flows from investing activities:      
Acquisition of real estate properties (145,278) (128,908) (215,833)
Disposition of real estate properties 58,137 68,137 26,802
Capital expenditures (37,399) (45,625) (40,426)
Cash flow (used in) investing activities (124,540) (106,396) (229,457)
Cash flows from financing activities:      
Proceeds from issuance of common stock 148,213 20,981 21,914
Proceeds from unsecured credit facility and term loan 195,501 234,059 400,000
Unsecured credit facility repayments (197,000) (153,500) (198,262)
Mortgage principal repayments (39,785) (4,284) (3,191)
Payments for deferred financing costs (50) (1,446) (890)
Distributions on common stock (56,146) (64,745) (52,476)
Distributions to noncontrolling interests (480) (640) (658)
Payment for interest rate collars     (3,730)
Repurchase of shares related to equity award tax withholding (1,490) (642) (354)
Net cash provided by financing activities 48,763 29,783 162,353
Net change in cash and cash equivalents, and restricted cash (818) (1,612) 1,426
Cash and cash equivalents, and restricted cash, beginning of period 14,433 16,045 14,619
Cash and cash equivalents, and restricted cash, end of the period 13,615 14,433 16,045
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet      
Cash and cash equivalents 8,751 9,888 9,316
Restricted cash 4,864 4,545 6,729
Cash and cash equivalents, and restricted cash, end of the period 13,615 14,433 16,045
Supplemental cash flow information:      
Cash paid for interest 34,105 37,531 36,002
Supplemental disclosure of noncash investing and financing activities:      
Decrease in noncontrolling interest from conversion of common limited partnership units to shares of common stock 1,372 78 14,506
Distributions declared but not paid 12,257 16,491 16,162
Mortgage debt assumed     54,756
Initial measurement of operating lease right of use assets 169 2,812  
Initial measurement of operating lease liabilities 169 3,176  
Debt extinguishment costs included in net gains (losses) on sale of assets   7,417 911
Capital expenditure accrual $ 413 $ 804 $ 1,750